Dr.U.M. Nagmalesh

Dr.U.M. Nagmalesh
Interventional Cardiologist, Bangalore

MBBS, MD, DNB (Cardiology)

  • 1 Hospital
  • 13 Years Experience


Specialities

  • Interventional Cardiology

Expertise

Radial Angioplasty
Carotid Angioplasty

Education

MBBS, JSS Medical College, Mysore, India

MD (Medicine), JSS Medical College, Mysore, India

Practice Information

M S Ramaiah Narayana Hrudayalaya Heart Center, Bangalore

M S Ramaiah Narayana Hrudayalaya Heart Center, Bangalore

M S R I T Post, New B E L Road, Bangalore, Karnataka - 560054

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.U.M. Nagmalesh and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Principal Investigator: Indian heart rhythm registry of atrial fibrillation patients characteristics and clinical management practices. (Phase-Registry)
  • Sub-Investigator: A multicentre, randomized, double blind, parall group, active controlled study to evaluate the efficacy and safety of study drug compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction. (Phase-III)
  • Sub-Investigator: A randomized double blind trial to evaluate study drug versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. (Phase-III)
  • Sub-Investigator: Heart Failure with anaemia. (Phase-III)
  • Sub-Investigator: Evaluation of safety and efficacy of short term study drug treatment in subject with Acute Coronary Syndrome. (Phase-III)
  • Sub-Investigator: CCF with Hypernatremia. (Phase-III)
  • Sub-Investigator: A phase 3 Active controlled (warfarin) randomized, double blind, parallel arm study to evaluate efficacy and safety of study drug in preventing stroke and systemic embolism in subject with non valvular Atrial Fibrillation. (Phase-II)
  • Sub-Investigator: Acute Coronary Syndrome. (Phase-III). 2009-2010.Sub-Investigator: A double blind, randomized placebo controlled multicenter study assessing the impact of additional LDL-Cholesterol reduction in major cardiovascular events when AMG145 is used in combination with statins therapy in patients with clinically evident cardiovascular disease. (Phase-III)
  • Acute Coronary Syndrome among young Indian women single centre experience. International journal of clinical case and investigations 2013, volume 5(issue 5), 60; 77, 1st April 2014 
  • Cross sectional observational survey evaluating myocardial infarction, risk  profile & management. International journal of clinical case and investigations 2013, volume 5(issue 5), 60; 77, 1st April 2014
  • Co-existing dual rhythm-sinus and left atrial flutter post Wide Antrum Circumferential Ablation (WACA) plus atrial roof line and lataral mitral ischmus ablation. Journal of arrhythmia: suppl 2012 ,vol 28, p 221
  • Arrhythmogenic focus in ARVD  mimicking ischemic ventricular tachycardia predominant involvement of interventricular septum. Journal of arrhythmia :suppl 2012, vol 28, p 311
  • Isolated supravalvular aortic stenosis stenosis with with left ventricular diverticulam cleft mitral valve; surgical repair in adult hood.
  • Member, Cardiology Society of India
  • Member, Indian Academy of Echocardiography
  • Executive committee member Cardiology Society of India, Bangalore
  • Executive committee member Cardiology Society of India, Karnataka
  • Secretary, Cardiology Society of India, Bangalore Chapter